1887
Preview this article:
Zoom in
Zoomout

Use of ciprofloxacin for treating leptospirosis – need for clinical trials, Page 1 of 1

| /docserver/preview/fulltext/jmm/54/9/907-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45978-0
2005-09-01
2020-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/9/JM540918.html?itemId=/content/journal/jmm/10.1099/jmm.0.45978-0&mimeType=html&fmt=ahah

References

  1. Bharadwaj R., Bal A. M., Joshi S. A., Kagal A., Pol S. S., Garad G., Arjunwadkar V., Katti R. 2002; An urban outbreak of leptospirosis in Mumbai, India. Jpn J Infect Dis 55:194–196
    [Google Scholar]
  2. Emmanouilides C. E., Kohn O. F., Garibaldi R. 1994; Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report. Clin Infect Dis 18:1004–1006 [CrossRef]
    [Google Scholar]
  3. Guidugli F., Castro A. A., Atallah A. N. 2000; Antibiotics for treating leptospirosis. Cochrane Database Syst Rev 2: CD001306. CD001306
    [Google Scholar]
  4. Gussenhoven G. C., van der Hoorn M. A., Goris M. G., Terpstra W. J., Hartskeerl R. A., Mol B. W., van Ingen C. W., Smits H. L. 1997; LEPTO dipstick, a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human sera. J Clin Microbiol 35:92–97
    [Google Scholar]
  5. Hooper D. C. 2000; Quinolones. In Principles and Practice of Infectious Diseases pp 404–423 Edited by Mandell G. L, Bennett J. E, Dolin R. Philadelphia: Churchill Livingstone;
    [Google Scholar]
  6. Mancel E., Merien F., Pesenti L., Salino D., Angibaud G., Perolat P. 1999; Clinical aspects of ocular leptospirosis in New Caledonia (South Pacific). Aust N Z J Ophthalmol 27:380–386 [CrossRef]
    [Google Scholar]
  7. Shalit I., Barnea A., Shahar A. 1989; Efficacy of ciprofloxacin against Leptospira interrogans serogroup icterohaemorrhagiae. Antimicrob Agents Chemother 33:788–789 [CrossRef]
    [Google Scholar]
  8. Sugunan A. P., Natarajaseenivasan K., Vijayachari P., Sehgal S. C. 2004; Percutaneous exposure resulting in laboratory-acquired leptospirosis – a case report. J Med Microbiol 53:1259–1262 [CrossRef]
    [Google Scholar]
  9. Takashima I., Ngoma M., Hashimoto N. 1993; Antimicrobial effects of a new carboxyquinolone drug, Q-35, on five serogroups of Leptospira interrogans . Antimicrob Agents Chemother 37:901–902 [CrossRef]
    [Google Scholar]
  10. Tappero J. W., Ashford D. A., Perkins B. A. 2000; Leptospira species (Leptospirosis. In Principles and Practice of Infectious Diseases pp 2495–2501 Edited by Mandell G. L, Bennett J. E, Dolin R. Philadelphia: Churchill Livingstone;
    [Google Scholar]
  11. Truccolo J., Charavay F., Merien F., Perolat P. 2002; Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 46:848–853 [CrossRef]
    [Google Scholar]
  12. Watt G., Padre L. P., Tuazon M. L., Calubaquib C., Santiago E., Ranoa C. P., Laughlin L. W. 1988; Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet i:433–435
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45978-0
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error